Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin.
暂无分享,去创建一个
Norbert Maurer | M. Johnston | P. Cullis | N. Maurer | S. Semple | S. Ansell | S. Klimuk | Pieter R Cullis | Michael J W Johnston | Sean C Semple | Sandy K Klimuk | Steve Ansell
[1] D. Vance,et al. Biochemistry of Lipids and Membranes , 1985 .
[2] J. Slotte,et al. Analysis of natural and synthetic sphingomyelins using high-performance thin-layer chromatography. , 1999, European journal of biochemistry.
[3] M. Woodle,et al. Long Circulating Liposomes: Old Drugs, New Therapeutics , 1998, Biotechnology Intelligence Unit.
[4] K. Edwards,et al. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[5] M. Bally,et al. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone. , 1997, The Journal of pharmacology and experimental therapeutics.
[6] P. Cullis,et al. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. , 1992, The Journal of biological chemistry.
[7] P. Cullis,et al. Ionophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradients. , 1998, Biochimica et biophysica acta.
[8] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[9] M. Bally,et al. Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin , 2004, Cancer Chemotherapy and Pharmacology.
[10] Y. Oh,et al. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.
[11] J. Slotte,et al. Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species. , 2001, Biophysical journal.
[12] A. J. Clifford,et al. BIOCHIMICA ET BIOPHYSICA ACTA , 2022 .
[13] P. Cullis,et al. Influence of dose on liposome clearance: critical role of blood proteins. , 1996, Biochimica et biophysica acta.
[14] M. Bally,et al. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.
[15] M. Bally,et al. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. , 1989, Cancer research.
[16] M. Bally,et al. Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia , 2004, Cancer Chemotherapy and Pharmacology.
[17] A. Gabizon. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.
[18] M. Bally,et al. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. , 1990, Cancer research.
[19] C. H. Fiske,et al. THE COLORIMETRIC DETERMINATION OF PHOSPHORUS , 1925 .
[20] D. Borchman,et al. Separation and characterization of the unknown phospholipid in human lens membranes. , 1994, Investigative ophthalmology & visual science.
[21] P. Cullis,et al. Influence of cholesterol on the association of plasma proteins with liposomes. , 1996, Biochemistry.
[22] L. Mayer,et al. Optimization of the retention properties of vincristine in liposomal systems. , 1993, Biochimica et biophysica acta.
[23] M. Johnston,et al. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. , 2006, Biochimica et biophysica acta.
[24] E. P. Kennedy,et al. Metabolism of labeled dihydrosphingomyelin in vivo. , 1968, Journal of lipid research.
[25] T. Tadakuma,et al. Temperature-sensitive release of adriamycin, an amphiphilic antitumor agent, from dipalmitoylphosphatidylcholine-cholesterol liposomes. , 1989, Biochimica et biophysica acta.
[26] A. Spector,et al. Membrane cholesterol and phospholipid in consecutive concentric sections of human lenses. , 1985, Journal of lipid research.
[27] K. Edwards,et al. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. , 2005, Journal of pharmaceutical sciences.
[28] F. Dosio,et al. From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy , 2003, Tumori.
[29] M. Bally,et al. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. , 1998, Biochimica et biophysica acta.
[30] G Gregoriadis,et al. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.
[31] M. Bally,et al. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. , 1995, British Journal of Cancer.
[32] S. Zellmer,et al. Tumor targeting in vivo by means of thermolabile fusogenic liposomes. , 1996, Journal of drug targeting.
[33] F. Goebel,et al. Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin. , 1998, European journal of medical research.
[34] L. Mayer,et al. Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.
[35] C. Leonetti,et al. In vivo administration of liposomal vincristine sensitizes drug‐resistant human solid tumors , 2004, International journal of cancer.
[36] G. Hahn,et al. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. , 1994, International journal of radiation oncology, biology, physics.
[37] P. Cullis,et al. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.
[38] D. Papahadjopoulos,et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.
[39] P. Cullis,et al. Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. , 1998, Biochimica et biophysica acta.
[40] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[41] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.